VALBY, Denmark, April 4, 2025 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) will present positive interim results from the open-label extension of the PACIFIC trial investigating bexicaserin, in addition to new analyses from clinical trials and real-world data with eptinezumab. H. Lundbeck...
Read More Details
Finally We wish PressBee provided you with enough information of ( Lundbeck to present positive pipeline data at American Academy of Neurology (AAN) Annual Meeting )
Also on site :
- Fan-Favorite Tex-Mex Chain Unveils Limited-Edition Flamin’ Hot Menu Collab
- 'Avoid the area': Novato police issue shelter-in-place order
- Sonic’s New Spring Drink Has Fans Declaring ‘Yes Please’